Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients

  • Won S
  • Han D
  • Seo J
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Iron overload is a predictable and life-threatening complication in patients dependent on the regular transfusion of RBCs. The aims of this study were to investigate the efficacy and safety of deferiprone in a variety of pediatric hematologic and/or oncologic patients with a high iron overload.

Cite

CITATION STYLE

APA

Won, S. C., Han, D. K., Seo, J. J., Chung, N. G., Park, S. K., Park, K. B., … Lyu, C. J. (2010). Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients. The Korean Journal of Hematology, 45(1), 58. https://doi.org/10.5045/kjh.2010.45.1.58

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free